GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,047 Cr | ₹-1,831 Cr | ₹-90 Cr | ₹994 Cr | ₹970 Cr |
What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹1,047 Cr |
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-90 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹970 Cr |
How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,047 Cr | Positive | |
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-90 Cr | Negative | |
| Mar2023 | ₹994 Cr | 2.43 | |
| Mar2022 | ₹970 Cr | - | |
Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹69,539.7 Cr | 1% | 13.1% | 27.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1% |
13.1% |
27.5% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses